Executive Dysfunction, Heart Disease Burden, and Remission of Geriatric Depression
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
This study investigated the relationship of executive impairment and heart disease burden to remission of major depression among elderly patients. A total of 112 elderly subjects suffering from major depression received treatment with citalopram at a target daily dose of 40 mg for 8 weeks. Diagnosis was assigned using the Research Diagnostic Criteria and the DSM-IV Criteria after an interview with the Schedule for Affective Disorders and Schizophrenia. Executive dysfunction was assessed with the Initiation/Perseveration subscale of the Dementia Rating Scale (DRS) and the Color-Word Stroop test. Medical burden, including heart disease burden, was rated with the Cumulative Illness Rating Scale, and disability with Philadelphia Multilevel Instrument. Both abnormal initiation/perseveration and abnormal Stroop scores were associated with low remission rates of geriatric depression. Similarly, heart disease burden and baseline severity of depression also predicted low remission rates. The relationship of heart disease burden to remission was not mediated by executive dysfunction. Impairment in other DRS cognitive domains, disability, medical burden unrelated to heart disease did not significantly influence the outcome of depression in this sample. Executive dysfunction and heart disease burden constitute independent vulnerability factors that increase the risk for chronicity of geriatric depression. The findings of this study provide the rationale for investigation of the role of specific frontostriatal-limbic pathways in predisposing to geriatric depression or worsening its course.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Executive dysfunction predicts poor response of LLD to antidepressants and early relapse and recurrence32–38.”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [35]
In the citing paper
“Problem solving therapy was more effective that supportive therapy in reducing depression and disability in older adults with DED162,163, a syndrome with poor response to antidepressants32–38,164.”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [35]
In the citing paper
“The depression-executive dysfunction (DED) syndrome has a slow or poor response to antidepressants32–38,164.”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [35]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Research Diagnostic Criteria: Rationale and Reliability
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,951
Cognitive and emotional influences in anterior cingulate cortex
Bush, G., Luu, P., & Posner, M. I. (2000) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(00)01483-2 · Cited by 6,259 · cited 1×
“Finally, response inhibition tasks, like those of the Stroop test, lead to activation of the anterior cingulate cortex (Bush et al, 2000; Davidson et al, 2002).”
Miller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990 · cited 3×
“The CIRS-G rates chronic medical burden from 14 organ-systems.”
MethodInfluential'Vascular Depression' Hypothesis
Alexopoulos, G. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220033006 · Cited by 1,843 · cited 3×
“Patients with either evidence of peripheral vascular disease (Alexopoulos et al, 2002b, 1997b) or white matter hyperintensities (Krishnan et al, 1997) have impairment of executive functions, psychomotor retardation, reduced interest in activities, and limited insight, a clinical presentation…”
Self-citationLimbic-cortical dysregulation: a proposed model of depression
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.471 · Cited by 1,585 · cited 1×
“…of the rostral anterior cingulate was reported in treatment-resistant depression, while cingulate hypermetabolism was associated with favorable response (Mayberg, 1997; Mayberg et al, 1997); integrity of the anterior cingulate is required for the executive functions tested by the IP and the Stroop.”
Neuroimaging studies of mood disorders
Drevets, W. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01020-9 · Cited by 1,313
Depression: Perspectives from Affective Neuroscience
Davidson, R. J., Pizzagalli, D., Nitschke, J. B., & Putnam, K. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135148 · Cited by 1,138
Cingulate function in depression: a potential predictor of treatment response
Mayberg, H. S., Brannan, S. K., Mahurin, R. K., Jerabek, P. A., Brickman, J. S., Tekell, J. L., Silva, J. A., McGinnis, S., Glass, T. G., Martin, C. C., et al. (1997) · NeuroReport · doi:10.1097/00001756-199703030-00048 · Cited by 1,029
Research works printed but not linked: 2
- Golden CJ (1978). The Stroop Color and Word Test (Manual). Stoetling: Chicago.
- Mayberg HS, Solomon DH (1995). Depression in Parkinson's disease: a biochemical and organic viewpoint, in behavioral neurology of movement disorders. In: Weiner WJ, Lang AE (eds). Advances in Neurology, Vol. 65. Raven Press: New York. pp 49–60.
Cited by
Alexopoulos, G. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66665-2 · Cited by 2,024
Self-citationAging and motivated cognition: the positivity effect in attention and memory
Mather, M., & Carstensen, L. L. (2005) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2005.08.005 · Cited by 1,910
“This hypothesis could help to explain why older adults who have sustained strokes or microvascular lesions in frontal brain regions and have impaired executive processes are prone to latelife onset of depression [52,53] that is not responsive to antidepressant medications [54–56].”
BackgroundThe vascular depression hypothesis: mechanisms linking vascular disease with depression
Taylor, W. D., Aizenstein, H. J., & Alexopoulos, G. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.20 · Cited by 923
Self-citationLespérance, F., Frasure-Smith, N., Koszycki, D., Laliberté, M.-A., van Zyl, L. T., Baker, B., Swenson, J. R., Ghatavi, K., Abramson, B. L., Dorian, P., et al. (2007) · JAMA · doi:10.1001/jama.297.4.367 · Cited by 658
Gliogenesis and Glial Pathology in Depression
Rajkowska, G., & Miguel-Hidalgo, J. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780619326 · Cited by 610
Mechanisms and treatment of late-life depression
Alexopoulos, G. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0514-6 · Cited by 592
Self-citationMillan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
“A poor esponse to antidepressant therapy is seen particularly in older atients who have high vascular risks (Iosifescu et al., 2005), includng burden of cardiac disease (Alexopoulos et al., 2004), and high evels of cholesterol (Sonawalla et al., 2002; Papakostas et al., 2003, 004).”
BackgroundElectroconvulsive Therapy for Depression
Lisanby, S. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmct075234 · Cited by 503
Alexopoulos, G. S., Hoptman, M. J., Kanellopoulos, D., Murphy, C. F., Lim, K. O., & Gunning, F. M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.002 · Cited by 437
“Abnormal response inhibition, working memory, and processing speed, characterize depressed elderly non-remitters or predict long time to remission (Sheline et al., 2010b, Alexopoulos et al., 2005, Alexopoulos et al., 2004, Kalayam and Alexopoulos, 1999).”
BackgroundSelf-citationExecutive dysfunction and the course of geriatric depression
Alexopoulos, G. S., Kiosses, D. N., Heo, M., Murphy, C. F., Shanmugham, B., & Gunning-Dixon, F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.024 · Cited by 317
Self-citationIsingrini, E., Camus, V., Le Guisquet, A.-M., Pingaud, M., Devers, S., & Belzung, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010404 · Cited by 277
“Moreover, cardiovascular risk factors like aging, smoking, hypertension, diabetes, hypercholesterolemia and advanced heart disease predict a poor response to fluoxetine/ citalopram treatment and lack of remission [8,9].”
BackgroundOutcomes of Minor and Subsyndromal Depression among Elderly Patients in Primary Care Settings
Lyness, J. M., Heo, M., Datto, C. J., Ten Have, T. R., Katz, I. R., Drayer, R., Reynolds, C. F., Alexopoulos, G. S., & Bruce, M. L. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-7-200604040-00008 · Cited by 271
Self-citationEscitalopram Therapy for Major Depression and Anxiety Disorders
Baldwin, D. S., Reines, E. H., Guiton, C., & Weiller, E. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k089 · Cited by 228
Alexopoulos, G. S., Raue, P. J., Kiosses, D. N., Mackin, R. S., Kanellopoulos, D., McCulloch, C., & Areán, P. A. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.177 · Cited by 199
Self-citationResting state functional connectivity and treatment response in late-life depression
Andreescu, C., Tudorascu, D. L., Butters, M. A., Tamburo, E., Patel, M., Price, J., Karp, J. F., Reynolds, C. F., & Aizenstein, H. (2013) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2013.08.007 · Cited by 153
Rajkowska, G., Miguel-Hidalgo, J. J., Dubey, P., Stockmeier, C. A., & Krishnan, K. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.013 · Cited by 172
“…independent nonvascular factors, such as atrophy of fronto– limbic brain regions, impaired neuronal plasticity, or comorbidity with nonvascular medical conditions related to age, might also predispose for late-life depression (Alexopoulos et al 2004; Kumar et al 2000, 2002; Mattson et al 2004).”
BackgroundDepression and Cognitive Function in Maintenance Hemodialysis Patients
Agganis, B. T., Weiner, D. E., Giang, L. M., Scott, T. M., Tighiouart, H., Griffith, J. L., & Sarnak, M. J. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.04.018 · Cited by 154
Escitalopram in the treatment of major depressive disorder: A meta-analysis
Kennedy, S. H., Andersen, H. F., & Thase, M. E. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802622726 · Cited by 140
Diagnosis and treatment of depression and cognitive impairment in late life
Morimoto, S. S., Kanellopoulos, D., Manning, K. J., & Alexopoulos, G. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12669 · Cited by 138
Self-citationEscitalopram: A Review of its Use in the Management of Major Depressive Disorder
Murdoch, D. R., & Keam, S. J. (2005) · Drugs · doi:10.2165/00003495-200565160-00013 · Cited by 130
Pimontel, M. A., Rindskopf, D., Rutherford, B. R., Brown, P. J., Roose, S. P., & Sneed, J. R. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.05.010 · Cited by 110
A Systematic Review of Cognitive Predictors of Treatment Outcome in Major Depression
Groves, S. J., Douglas, K. M., & Porter, R. J. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00382 · Cited by 105
“Five of the studies found that deficits in executive functioning were associated with poor remission rates/antidepressant response (combined n= 341) (26, 28, 29, 32, 34, 35).”
BackgroundA model for streamlining psychotherapy in the RDoC era: the example of ‘Engage’
Alexopoulos, G. S., & Arean, P. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.150 · Cited by 95
Self-citationMcLennan, S. N., & Mathias, J. L. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2431 · Cited by 95
“Two studies were excluded (Portella et al., 2003; Alexopoulos et al., 2004) because they presented data that had already been reported in another publication (Alexopoulos et al.”
BackgroundResultA longitudinal analysis of neurocognitive function in unipolar depression
Biringer, E., Mykletun, A., Sundet, K., Kroken, R., Stordal, K. I., & Lund, A. (2007) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390601147686 · Cited by 95
Kiosses, D. N., Arean, P. A., Teri, L., & Alexopoulos, G. S. (2010) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181d6947d · Cited by 93
Self-citationMorimoto, S. S., Wexler, B. E., Liu, J., Hu, W., Seirup, J., & Alexopoulos, G. S. (2014) · Nature Communications · doi:10.1038/ncomms5579 · Cited by 91
Self-citationResearch advances in geriatric depression
ALEXOPOULOS, G. S., & KELLY, R. E. (2009) · World Psychiatry · doi:10.1002/j.2051-5545.2009.tb00234.x · Cited by 88
“poor and unstable response to antidepressants (35,37-39).”
Self-citationEcosystem focused therapy in poststroke depression: a preliminary study
Alexopoulos, G. S., Wilkins, V. M., Marino, P., Kanellopoulos, D., Reding, M., Sirey, J. A., Raue, P. J., Ghosh, S., O'Dell, M. W., & Kiosses, D. N. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2822 · Cited by 88
“Abnormal performance in the Stroop Color Word test has been associated with poor response of geriatric depression to citalopram (Alexopoulos et al., 2004; Alexopoulos et al., 2005) but not to problem solving therapy (Arean et al., 2010; Alexopoulos et al., 2011).”
Self-citationIncomplete response in late-life depression: getting to remission
Lenze, E. J., Sheffrin, M., Driscoll, H. C., Mulsant, B. H., Pollock, B. G., Amanda Dew, M., Lotrich, F., Devlin, B., Bies, R., & Reynolds III, C. F. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/jlenze · Cited by 79
Cognitive Deficits in Geriatric Depression
Morimoto, S. S., & Alexopoulos, G. S. (2013) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2013.08.002 · Cited by 90
“Instead, it is a stable disturbance that improves only mildly when depressive symptoms are ameliorated (26, 74, 75).”
BackgroundSelf-citationZhukovsky, P., Anderson, J. A. E., Coughlan, G., Mulsant, B. H., Cipriani, A., & Voineskos, A. N. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.21010088 · Cited by 87
Iosifescu, D. V., Clementi-Craven, N., Fraguas, R., Papakostas, G. I., Petersen, T., Alpert, J. E., Nierenberg, A. A., & Fava, M. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000170338.75346.d0 · Cited by 72
Antidepressant response trajectories and associated clinical prognostic factors among older adults
Smagula, S. F., Butters, M. A., Anderson, S. J., Lenze, E. J., Dew, M. A., Mulsant, B. H., Lotrich, F. E., Aizenstein, H., & Reynolds, C. F. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1324 · Cited by 71
Anterior cingulate dysfunction in geriatric depression
Alexopoulos, G. S., Gunning‐Dixon, F. M., Latoussakis, V., Kanellopoulos, D., & Murphy, C. F. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1939 · Cited by 71
“These observations were replicated (Alexopoulos et al., 2004, 2005a; Marcos et al., 2005; Bogner et al., 2007).”
MethodSelf-citationLate-Life Depression: A Model for Medical Classification
Alexopoulos, G. S., Schultz, S. K., & Lebowitz, B. D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.055 · Cited by 68
Self-citationCognitive Impairment in Depressed Older Adults: Implications for Prognosis and Treatment
Morimoto, S. S., Kanellopoulos, T., & Alexopoulos, G. S. (2014) · Psychiatric Annals · doi:10.3928/00485713-20140306-05 · Cited by 66
Self-citationO'Shea, D. M., Fieo, R. A., Hamilton, J. L., Zahodne, L. B., Manly, J. J., & Stern, Y. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4192 · Cited by 63
“, 1997) are related to the onset of some ‘subtypes’ of depression (Krishnan, 2002; Alexopoulos et al., 2004; Geerlings et al., 2012).”
BackgroundNicotine and networks: Potential for enhancement of mood and cognition in late-life depression
Gandelman, J. A., NEWHOUSE, P. A., & Taylor, W. D. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.018 · Cited by 68
“…best studied domain, with several studies associating executive dysfunction with poor acute treatment response, lower remission rates, and increased relapse and recurrence rates (Alexopoulos et al., 2004, 2002, 2000; Kalayam and Alexopoulos, 1999; McLennan and Mathias, 2010; Pimontel et al., 2012).”
Baseline severity of depression predicts antidepressant drug response relative to escitalopram
Kilts, C. D., Wade, A. G., Andersen, H. F., & Schlaepfer, T. E. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902849258 · Cited by 58
Executive Function and Short-Term Remission of Geriatric Depression: The Role of Semantic Strategy
Morimoto, S. S., Gunning, F. M., Murphy, C. F., Kanellopoulos, D., Kelly, R. E., & Alexopoulos, G. S. (2011) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181e751c4 · Cited by 57
“19 Exclusion criteria are as follows: (1) major depression with psychotic features (according to DSM-IV-TR); (2) history of other psychiatric disorders (except personality disorders) before the onset of depression; (3) severe medical illness (i.”
Self-citationDemyttenaere, K., Andersen, H. F., & Reines, E. H. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328303ac5f · Cited by 55
“…65 30.5 (4.1) 29.8 Kasper et al. (2005) Escitalopram 10–20 143 38 (12) 56 30.4 (4.0) 49.0 Flexible dose in MDD 8 weeks Placebo 132 41 (12) 57 30.7 (4.8) 42.4 Alexopoulos et al. (2004) Escitalopram 10–20 131 40 (11) 49 30.4 (4.4) 59.5 Sertraline 50–100 135 40 (11) 61 30.1 (4.6) 62.2 aZ50%…”
BackgroundInfluentialPredictors of serious suicidal behavior in late-life depression
Szántó, K., Galfalvy, H., Kenneally, L. B., Almasi, R. C., & Dombrovski, A. Y. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.06.005 · Cited by 59
“Executive dysfunction may increase the frequency of suicidal ideation and interfere with treatment progress, as it is associated with greater levels of disability (Alexopoulos et al., 2004) and poorer illness outcomes in late-life depression (Alexopoulos et al.”
BackgroundWang, L., Liu, L., Liu, X., & Yang, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-71488-y · Cited by 61
Morimoto, S. S., Altizer, R., Gunning, F. M., Hu, W., Liu, J., Cote, S. E., Nitis, J., & Alexopoulos, G. S. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.05.023 · Cited by 56
Self-citationEscitalopram for the treatment of major depression and anxiety disorders
Höschl, C., & Švestka, J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.537 · Cited by 50
Developing an intervention for depressed, chronically medically ill elders: A model from COPD
Alexopoulos, G. S., Raue, P. J., Sirey, J. A., & Arean, P. A. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1925 · Cited by 48
“Impairment in some executive functions predicts poor or slow response to antidepressant treatment (Kalayam and Alexopoulos, 1999; Alexopoulos et al., 2004; Potter et al., 2004), as well as early relapse and recurrence of geriatric depression (Alexopoulos et al.”
BackgroundSelf-citationBogner, H. R., Bruce, M. L., Reynolds, C. F., Mulsant, B. H., Cary, M. S., Morales, K., & Alexopoulos, G. S. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1767 · Cited by 48
“…consisted mainly of pharmacotherapy which is a treatment modality to which many depressed patients with executive dysfunction respond poorly (Kalayam and Alexopoulos, 1999; Alexopoulos et al., 2000; Dunkin et al., 2000; Alexopoulos et al., 2004; Potter et al., 2004; Alexopoulos et al., 2005b).”
BackgroundInfluentialNaturalistic outcomes of minor and subsyndromal depression in older primary care patients
Lyness, J. M. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1982 · Cited by 45
“…of particular interest are executive functions such as initiation, perseveration, and mental set shifting, which some (Alexopoulos, 2003; Alexopoulos et al., 2000, 2004) but not all (Butters et al., 2004) studies suggest may be specifically associated with late-life depression,…”
BackgroundSemantic organizational strategy predicts verbal memory and remission rate of geriatric depression
Morimoto, S. S., Gunning, F. M., Kanellopoulos, D., Murphy, C. F., Klimstra, S. A., Kelly, R. E., & Alexopoulos, G. S. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2743 · Cited by 44
“Alexopoulos, 1999; Alexopoulos et al., 2004; Alexopoulos et al., 2008; Gunning‐Dixon et al., 2010).”
Self-citationAlexopoulos, G. S., Manning, K., Kanellopoulos, D., McGovern, A., Seirup, J. K., Banerjee, S., & Gunning, F. (2015) · Psychological Medicine · doi:10.1017/s0033291715001075 · Cited by 43
“…that poor performance in cognitive control tasks is a rather specific predictor of poor outcome to treatment with at least some antidepressants (Alexopoulos et al. 2004, 2005; Sneed et al. 2008; Morimoto et al. 2011), it is possible that such patients may do well with other antidepressant…”
BackgroundResultSelf-citationCourse and outcomes of depression in the elderly
Kohn, R., & Epstein-Lubow, G. P. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0079-y · Cited by 50
Yin, J., Song, X., Wang, C., Lin, X., & Miao, M. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05382-8 · Cited by 51
Neuroplasticity‐based computerized cognitive remediation for geriatric depression
Morimoto, S. S., Wexler, B. E., & Alexopoulos, G. S. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3776 · Cited by 37
“Studies, including ours, suggest that older patients with major depression often exhibit de fi cits in select executive functions that predispose them to poor antidepressant treatment response, increase the risk of relapse (Kalayam and Alexopoulos 1999; Alexopoulos et al .”
BackgroundResultInfluentialSelf-citationA home‐delivered intervention for depressed, cognitively impaired, disabled elders
Kiosses, D. N., Teri, L. L., Velligan, D. I., & Alexopoulos, G. S. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2521 · Cited by 40
“First, both patients were at risk for poor response to antidepressant medication because of their cognitive impairment, and especially, their executive dysfunction (Kalayam and Alexopoulos, 1999; Alexopoulos et al., 2004; Sneed et al., 2007).”
BackgroundSelf-citationCognitive Predictors of Response to Treatment for Depression in Multiple Sclerosis
Julian, L. J., & Mohr, D. C. (2006) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.18.3.356 · Cited by 34
Structural Neuroimaging Research Methods in Geriatric Depression
Hoptman, M. J., Gunning‐Dixon, F. M., Murphy, C. F., Lim, K. O., & Alexopoulos, G. S. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000238588.34205.bd · Cited by 33
Self-citationAn integrated model for defining the scope of psychogeriatrics: the five Cs
Sadavoy, J. (2009) · International Psychogeriatrics · doi:10.1017/s104161020999010x · Cited by 38
“executive dysfunction subtype of depression (Kalayam and Alexopoulos, 1999; Alexopoulos et al., 2004) 4.”
Executive Dysfunction in Elderly Bipolar Manic Patients
Gunning‐Dixon, F. M., Murphy, C. F., Alexopoulos, G. S., Majcher-Tascio, M., & Young, R. C. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318172b3ec · Cited by 33
Self-citationA model for intervention research in late‐life depression
Alexopoulos, G. S., & BRUCE, M. L. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2287 · Cited by 33
“, 2002b) and is associated with slow, poor response to antidepressants (Simpson et al., 1998; Kalayam and Alexopoulos, 1999; Alexopoulos et al., 2004; Sneed et al., 2007).”
Self-citationHomocysteine and Cognitive Function in Geriatric Depression
Alexopoulos, P., Topalidis, S., Irmisch, G., Prehn, K., Jung, S., Poppe, K. A., Sebb, H., Perneczky, R., Kurz, A., Bleich, S., et al. (2010) · Neuropsychobiology · doi:10.1159/000275821 · Cited by 30
Gandelman, J. A., Kang, H., Antal, A., Albert, K. M., Boyd, B. D., Conley, A. C., NEWHOUSE, P. A., & Taylor, W. D. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.18m12137 · Cited by 28
Resilience predicts remission in antidepressant treatment of geriatric depression
Laird, K. T., Lavretsky, H., St. Cyr, N., & Siddarth, P. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4953 · Cited by 23
Reductions in neuronal density in elderly depressed are region specific
Otterloo, E. V., O'Dwyer, G., Stockmeier, C. A., Steffens, D. C., Krishnan, R. R., & Rajkowska, G. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2281 · Cited by 26
“Executive dysfunction in elderly depressed has also been associated with a diminished response to certain antidepressants (Simpson et al., 1998; Kalayam and Alexopoulos, 1999; Dunkin et al., 2000; Alexopoulos et al., 2004; Potter et al., 2004; Alexopoulos et al., 2008).”
BackgroundSeparating mood disturbance from mild cognitive impairment in geriatric depression
Steffens, D. C. (2008) · International Review of Psychiatry · doi:10.1080/09540260802094589 · Cited by 26
Tissue-Specific Differences in Brain Phosphodiesters in Late-Life Major Depression
Harper, D. G., Jensen, J. E., Ravichandran, C. T., Sivrioğlu, Y., Silveri, M. M., Iosifescu, D. V., Renshaw, P. F., & Forester, B. P. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.08.005 · Cited by 26
Humphreys, J. M., Denson, L. A., Baker, R. A., & Tully, P. J. (2016) · 老年心脏病学杂志:英文版 · doi:10.11909/j.issn.1671-5411.2016.01.010 · Cited by 27
Dementia associated with psychiatric disorders
O'Brien, J. (2005) · International Psychogeriatrics · doi:10.1017/s1041610205002036 · Cited by 20
“An association between executive dysfunction and poor clinical outcome has been demonstrated (Alexopoulos et al., 2004), although whether this is mediated through psychological or organic cerebral factors is not known.”
BackgroundMechanisms and treatment of late-life depression
Alexopoulos, G. S. (2021) · Focus · doi:10.1176/appi.focus.19304 · Cited by 22
Self-citationMillan, M. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00001-1 · Cited by 23
Cognition as a therapeutic target in late-life depression: Potential for nicotinic therapeutics
Zurkovsky, L., Taylor, W. D., & NEWHOUSE, P. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.032 · Cited by 20
Relationship between Frailty and Depression in a Population from North-Eastern Romania
Maștaleru, A., Abdulan, I. M., Ștefăniu, R., Lefter, N., Sandu, I. A., Pîslaru, A. I., Leon, M. M., Alexa, I. D., & Ilie, A. C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095731 · Cited by 19
“In contrast, cognitive impairment is a stable disorder that only slightly improves when depressive symptoms subside [23,24].”
BackgroundDepression in the Elderly: The Unique Features Related to Diagnosis and Treatment
Shear, K. M., Ginsberg, D. L., Roose, S. P., Lenze, E. J., Alexopoulos, G. S., & Hollander, E. (2005) · CNS Spectrums · doi:10.1017/s1092852900027176 · Cited by 19
Self-citationTherapeutic relationship in the treatment of geriatric depression with executive dysfunction
Mace, R. A., Gansler, D. A., Suvak, M. K., Gabris, C., Areán, P. A., Raue, P. J., & Alexopoulos, G. S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.006 · Cited by 20
Self-citationDepression in context of low neuroticism is a risk factor for stroke: A 9-year cohort study
Marijnissen, R. M., Wouts, L., Schoevers, R. A., Bremmer, M. A., Beekman, A. T. F., Comijs, H. C., & Voshaar, R. C. O. (2014) · Neurology · doi:10.1212/wnl.0000000000000955 · Cited by 17
“Patients with depression with high levels of neuroticism are more likely to benefit from classical antidepressant treatment strategies, compared to patients with depression with higher level of vascular disease.(38,39) These latter patients are also at increased risk of future health events like stroke(4) and might be…”
BackgroundHabra, M. E., Baker, B., Frasure‐Smith, N., Swenson, J. R., Koszycki, D., Butler, G. S., van Zyl, L. T., & Lespérance, F. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.02.010 · Cited by 16
“[16] also found that heart disease burden, an index of history and severity of CAD, predicted low remission rates in elderly patients with MDD treated with citalopram.”
BackgroundBingham, K. S., Whyte, E. M., Meyers, B. S., Mulsant, B. H., Rothschild, A. J., Banerjee, S., & Flint, A. J. (2015) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.08.002 · Cited by 19
“The specificity of the depression executive dysfunction syndrome has been questioned, however, given that tests of nonexecutive cognitive domains have also been found to predict treatment outcome, suggesting LLD prognosis is related to cognitive impairment more globally.6 Some authors have proposed that slow informati…”
BackgroundMethodResultInfluentialCognitive dysfunction in elderly females with depressive symptoms
Tanaka, M., Ishii, A., Yamano, E., Ogikubo, H., Okazaki, M., Kamimura, K., Konishi, Y., Emoto, S., & Watanabe, Y. (2012) · Medical Science Monitor · doi:10.12659/msm.883596 · Cited by 9
Mewton, L. R., Reppermund, S., Crawford, J., Bunce, D. J., Wen, W. X., & Sachdev, P. S. (2018) · Psychological Medicine · doi:10.1017/s0033291718002994 · Cited by 10
“This is consistent with previous research that has shown that both executive dysfunction and WMH burden predict poor response to antidepressants in older samples (Kalayam and Alexopoulos, 1999; Alexopoulos et al., 2000; Alexopoulos et al., 2004; Baldwin et al., 2004; McLennan and Mathias, 2010; Sheline et al., 2010; M…”
ResultMarijnissen, R. M., Bus, B. A. A., Schoevers, R. A., Wouts, L., Holewijn, S., Franke, B., Graaf, J. D., den Heijer, M., & Voshaar, R. C. O. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.001 · Cited by 10
“Subsequently, the depression executive dysfunction (DED) syndrome has been introduced (Alexopoulos, 2005), validated by both treatment resistance of the DED syndrome (Alexopoulos et al, 2004) and by persisting cognitive deficits in case of remitted depression (Kohler et al, 2010).”
BackgroundDepression in vascular pathologies: the neurologist's point of view
Moretti, R., Bernobich, E., Francesca, E., Torre, P., Rodolfo, A., Angelis, L. D., & Bellini, G. (2011) · Vascular Health and Risk Management · doi:10.2147/vhrm.s20147 · Cited by 11
Göke, K., McClintock, S. M., Mah, L., Rajji, T. K., Lee, H. H., Nestor, S. M., Downar, J. H., Noda, Y., Daskalakis, Z. J., Mulsant, B. H., et al. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.07.009 · Cited by 17
Cohen, D. A., Sepehry, A. A., & Schultz, I. Z. (2019) · Psychological Injury and Law · doi:10.1007/s12207-019-09364-8 · Cited by 11
Understanding Depression and Cognitive Impairment in the Elderly
Walker, E. M., & Steffens, D. C. (2010) · Psychiatric Annals · doi:10.3928/00485718-20091229-03 · Cited by 8
Executive Functioning in Late-Life Depression
Manning, K. J., Alexopoulos, G. S., McGovern, A. R., Morimoto, S. S., Yuen, G. S., Kanellopoulos, T., & Gunning, F. M. (2014) · Psychiatric Annals · doi:10.3928/00485713-20140306-06 · Cited by 10
Self-citationConley, A. C., Key, A. P. F., Taylor, W. D., Albert, K. M., Boyd, B. D., Vega, J. N., & NEWHOUSE, P. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.721874 · Cited by 6
“Additional exclusion criteria included: (1) Current tobacco or nicotine use in last year; (2) Other psychiatric disorders, except for anxiety symptoms occurring during a depressive episode; (3) History of alcohol or drug abuse over last 3 years; (4) Primary neurological disorders including dementia; (5) Regular use of…”
BackgroundShan, Q., Liu, Q., & He, Y. V. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.08.017 · Cited by 6
Effects of heart disease on depression treatment: results from the COMED study
Kerber, K., Wisniewski, S. R., Luther, J. F., Leuchter, A. F., D’Empaire, I., Trivedi, M. H., & Rush, A. J. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.08.018 · Cited by 5
“Low rates of remission have been associated with HD burden in a geriatric population with depression [6].”
BackgroundRefining Evidence-Based Treatments for Late-Life Depression
Niu, G. C., & Areán, P. A. (2015) · GeroPsych · doi:10.1024/1662-9647/a000127 · Cited by 5
Assessment of Competence in Older Adults
Cohen, D. A., Schultz, I. Z., Sepehry, A. A., & Stewart, A. (2018) · Handbooks in health, work, and disability · doi:10.1007/978-3-030-03916-5_23 · Cited by 9
Motter, J. N., Pelton, G. H., D’Antonio, K., Rushia, S. N., Pimontel, M. A., Petrella, J. R., Garcon, E., Ciovacco, M., Sneed, J. R., Doraiswamy, P. M., et al. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4955 · Cited by 5
Research Advances in Geriatric Depression
Alexopoulos, G. S., & Kelly, R. E. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.107 · Cited by 5
Self-citationCognitive Impairment Associated With Depression in the Elderly
Roose, S. P., Devanand, D., Hamilton, R., Krishnan, K. R. R., Mayeux, R. P., & Small, G. W. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1020 · Cited by 6
Lin, C., Chou, L., Tang, S., & Huang, C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.09.026 · Cited by 4
Cognitive Behavioral Case Management for Depressed Low-income Older Adults
Areán, P. A., Alexopoulos, G. S., & Chu, J. P. (2007) · Springer eBooks · doi:10.1007/978-0-387-72007-4_14 · Cited by 4
Self-citationRemission is insufficient: predictors and mechanistic models of recurrence in late-life depression
Taylor, W. D., Gerlach, A., Szymkowicz, S. M., Gujral, S., & Andreescu, C. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02324-2 · Cited by 4
Morimoto, S. S., Manning, K. J., Kim, J. U., & Cote, S. E. (2018) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-018-0158-5 · Cited by 2
Kiosses, D., Ravdin, L., Banerjee, S., Wu, Y.-Y., Henderson, C. R., Pantelides, J., Petti, E., Maisano, J., Meador, L., Kim, P., et al. (2025) · The American journal of geriatric psychiatry · doi:10.1016/j.jagp.2024.12.008 · Cited by 2
Self-citationModerators of treatment response in late-life depression
Steffens, D. C., Diniz, B. S., Jain, N., Kluewer-DAmico, J., Manning, K. J., & Wang, L. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02337-x · Cited by 1
Metadata
- Authors
- Alexopoulos, G. S., Kiosses, D. N., Murphy, C., & Heo, M.
- Affiliations
- Cornell University (US)
- Corresponding author
- Alexopoulos, George S
- Venue
- Neuropsychopharmacology
- Published
- 2004-09-01
- Volume
- 29
- Issue
- 12
- Pages
- 2278-2284
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2068046798
- Cited by
- 117
- References
- 51
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 8 · 2017: 2 · 2016: 1 · 2015: 7 · 2014: 8 · 2013: 11 · 2012: 5
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (P30MH068638, R01-MH51842, RO1 MH42819, R01 MH42819, R01 MH65653, R01MH042819, P30 MH68638, R01MH065653, RO1 MH51842)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- executive dysfunction, geriatric depression, citalopram, elderly patients, Stroop task, Mattis Dementia Rating Scale, Cumulative Illness Rating Scale, disability, chronicity of depression, vulnerability factors
- MeSH terms
- Aged, Antidepressive Agents, Cognition Disorders, Major Depressive Disorder, Female, Heart Diseases, Humans, Male, Middle Aged, Neuropsychological Tests, Problem Solving, Psychiatric Status Rating Scales, Severity of Illness Index, Time Factors, Citalopram, Geriatric Assessment, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.